Mon panier

Rabies virus Nucleoprotein ELISA Kit

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
RAS-A195-96tests
$685.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Materials Provided

    ID
    Components
    Size
    RAS195-C01
    Pre-coated Anti-Nucleoprotein (RABV) Antibody Microplate
    1 plate
    RAS195-C02
    Nucleoprotein (RABV) Standard
    15 μg
    RAS195-C03
    Biotin-Anti-Nucleoprotein (RABV) Antibody
    15 μg
    RAS195-C04
    Streptavidin-HRP
    15 μg
    RAS195-C05
    10×Washing Buffer
    50 mL
    RAS195-C06
    2×Dilution Buffer
    50 mL
    RAS195-C07
    Substrate Solution
    12 mL
    RAS195-C08
    Stop Solution
    7 mL

  • Product Overview

    Rabies virus Nucleoprotein ELISA Kit is based on the sandwich-ELISA method and is used to detect and quantitatively determine Rabies virus Nucleoprotein (RABV-N) in vaccine samples. The kit is designed to provide a reliable solution for the manufacturing and quality control of RABV vaccine development.

  • Reconstitution

    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

  • Storage

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Typical Data 

    Please refer to DS document for the assay protocol.

     Nucleoprotein/NP (RABV) TYPICAL DATA

    For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs